In structure-based drug design (SBDD),
the molecular mechanics
generalized Born surface area (MM/GBSA) approach has been widely used
in ranking the binding affinity of small molecule ligands. However,
an accurate estimation of protein–ligand binding affinity still
remains a challenge due to the intrinsic limitation of the standard
generalized Born (GB) model used in MM/GBSA. In this study, we proposed
and evaluated the MM/GBSA approach based on a variable dielectric
generalized Born (VDGB) model using residue-type-based dielectric
constants. In the VDGB model, different dielectric values were assigned
for the three types of protein residues, and the magnitude of the
dielectric constants for residue types follows this order: charged
≥ polar ≥ nonpolar. We found that MM/GBSA based on a
VDGB model (MM/GBSAVDGB) with an optimal dielectric constant
of 4.0 for the charged residues and 1.0 for the noncharged residues
together with a net-charge-dependent dielectric value for ligands
achieved better predictions as judged by Pearson’s correlation
coefficient than the standard MM/GBSA with a uniform solute dielectric
constant of 4.0 for the training set of 130 protein–ligand
complexes. The prediction on the test set with 165 protein–ligand
complexes also validated the better performance of MM/GBSAVDGB. Moreover, this method exhibited potential in predicting the relative
binding free energies for multiple ligands against the same target.
Furthermore, we found that rational truncation of protein residues
far from the binding site can significantly speed up the MM/GBSAVDGB calculations, while it almost does not influence the prediction
accuracy. Therefore, it is feasible to implement the system-truncated
MM/GBSAVDGB as a scoring function for SBDD.